Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
Key Stock Data
The current last sale of $17.36 is 33.13% Higher than the 52 week low.
|Intraday||Last 52 Weeks|
|High:||$ 18.2796||$ 32.88|
|Low:||$ 17.10||$ 13.04|
Company Description (as filed with the SEC)
We are a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. We have a pipeline of product candidates, across various stages of development, focused on autoinflammatory and autoimmune conditions. We have three clinicalstage product candidates and two preclinicalstage product candidates. We follow a disciplined and methodical approach to selectively identify, discover and acquire product candidates with strong biologic rationales or validated mechanisms of action. We believe that our product candidates have the potential to address multiple indications. Our portfolio of product candidates offers multiple development opportunities. ... More ...
Nasdaq Official Price
Mar. 21, 2019
Mar. 21, 2019